KT Medical Service Public Company LimitedSET: KTMS🇹🇭 TH

Business Operation · 2025

Corporate Information

Company Name

KT Medical Service Public Company Limited

Telephone

0-2517-0274

Website

www.ktms.co.th

Email

cs@ktms.co.th

Dividend Policy

Dividend Policy

The Company has a policy to pay dividends to shareholders at a rate of not less than 40% of net profit after corporate income tax and legal reserves each year. The Company will consider dividend payments by taking into account various factors to primarily maximize benefits for shareholders, and such dividend payments must not significantly affect the Company's normal operations. However, such dividend payments may be subject to change, depending on the Company's operating results, financial position, liquidity, business expansion plans, any other future necessities and appropriateness, and other relevant factors in the Company's management as deemed appropriate or suitable by the Board of Directors. A resolution of the Board of Directors approving dividend payments must be submitted for approval at the shareholders' meeting, except for interim dividend payments, where the Board of Directors has the authority to approve such payments when it deems that the Company has sufficient profit to pay dividends without affecting the Company's operations, and will report this to the shareholders' meeting at the next meeting.

Historical Dividend Payments

This YearLast Year2 Years Ago3 Years Ago4 Years AgoMetricDescription
0.150.060.050.090.09Net profit per share (Baht : Share)Net profit per share (baht : share)
0.010.020.010.03Dividend per share (Baht : Share)Dividend per share (baht : share)
1111Dividend stock ratio (Number of original shares: dividend shares)Ratio of stock dividend payment (existing share : stock dividend)
0000Dividend share value per share (Baht : Share)Value of stock dividend per share (baht : share)
0.010.020.010.03Total dividend payment value (Baht : Share)Total dividend payment (baht : share)
8.7936.4629.635.01Dividend payout ratio to net profit (%)Dividend payout ratio compared to net profit (%)

Major Shareholders

Introduction

Shareholders holding at least 0.5 percent of the paid-up capital as of December 31, 2024, which is the record date.

Major Shareholders

No.NameShares% Shares
20,587FILTER VISION PUBLIC COMPANY LIMITED159,225,20053.08
20,588MISS KANJANA PONGPATTANADECHA20,752,3006.91
20,589SMEs PRIVATE EQUITY TRUST FUND211,150,0003.72
20,590SUCCESSMORE BEING PUBLIC COMPANY LIMITED7,993,6002.67
20,591MR. SATHID PREMCHUEN7,514,7552.5
20,592MS. RUNGRAPEEPORN WANNAPLUK5,500,0001.83
20,593MR. SUPACHAI PAIBOONPHOL3,600,0001.2
20,594MR. THEERAPAT SORNKLIN3,500,0001.17
20,595MR. WIJIT TECHAKASEM3,305,1211.1
20,596MR. BOONCHAI JIRAKRANONT3,000,0001
20,597MS. WIPAPORN SRIWICHA2,766,3670.92
20,598MR. SURAPONG KITCHAROEN2,454,4000.82
20,599MRS. SIRIWAN WANNAPLOOK1,556,4000.52
24,301MRS. NATLADA PROMMEE1,510,1000.5
25,027MRS. SIRIWAN CHUNGTHEERAPHANICH1,500,0000.5
25,028MR. THANIT KANANURAK1,500,0000.5

Business Strategies Overview

Introduction

To establish a unified direction and common goals for the "Group of Companies," the Company clearly defines its Vision, Mission, and Corporate Values in writing. The Vision represents the ultimate aspiration the Company aims to achieve. The Mission outlines the tasks and principles the Company adheres to in its business operations. The core Corporate Values are the shared principles that management and employees utilize to achieve objectives.

Chairman's Message

Message from the Chairman and Chief Executive Officer


I humbly offer my deepest condolences on the passing of Her Majesty Queen Sirikit, the Queen Mother, in October 2025. She was beloved by the Thai people and dedicated her life to the advancement of society. With profound gratitude for her boundless royal benevolence, may she ascend to heaven.

Dear Shareholders and Stakeholders,


The year 2025 was another challenging year for companies operating in the medical service industry, including KT Medical Services Public Company Limited ("the Company"). In the past year, the Company faced rapid challenges and changes in various aspects, including the needs of kidney disease patients and societal expectations. The Company continued to elevate the standards of care for kidney patients, both in terms of hemodialysis services, purified water production systems for hemodialysis, and comprehensive sales and medical-related services (One-stop Services).


With the company's commitment to delivering excellent specialized medical services for artificial kidney disease.
This has enabled the company to achieve significant growth and earn the trust of kidney patients, as well as the confidence and reliance of both public and private hospitals as partners. This underscores the company's commitment to quality, safety, and patient-centered care, with the aim of continuously improving the quality of life and providing benefits to kidney patients and their families. Furthermore, in 2025, KT Medical Services Public Company Limited faced a challenge as its artificial kidney unit at Vichaiyut Hospital successfully obtained certification from Joint Commission International (JCI) from the United States. This certification is awarded to healthcare facilities that adhere to international standards and fully implement requirements for patient safety and care. This achievement represents another source of pride for the company in receiving this prestigious accreditation.

At the same time, the company prioritizes three main factors: environment, society, and governance, as follows:

  1. Environmental Aspect (Environment): The company focuses on reducing environmental impact through efficient energy use, initiating projects to reduce greenhouse gas emissions, and responsibly managing medical waste.

  2. Social Aspect (Social): The company prioritizes the quality of life for kidney disease patients, medical personnel, and surrounding communities through the development of high-standard services, supporting access to medical treatment.
    equality and promoting workplace safety.

  3. Governance and Corporate Governance Aspect (Governance): We conduct business under principles of good governance, transparency, accountability, and consideration for the interests of all stakeholders, as well as promoting an organizational culture committed to ethics and responsibility.


In 2025, the company was rated as a listed company with good corporate governance at a 4-star level, or
"Excellent" in the Corporate Governance Report of Thai Listed Company (CGR) survey project from the Thai Institute of Directors (IOD) and a perfect score of 100 (5 stars) in the 2025 Annual General Meeting (AGM) Checklist assessment from the Thai Investors Association, supported by the Stock Exchange of Thailand (SET). This demonstrates the company's commitment to conducting business based on social and environmental responsibility, as well as meeting the expectations of all stakeholder groups.

The company's executive board is committed to driving continuous and stable growth for the company.
For the fiscal year 2025, total revenue was 704.72 Million Baht, Profit for the year 44.09 Million Baht (as of December 31, 2025) Total Assets 839.46 Million Baht, Total Liabilities 296.53 Million Baht and Shareholders' Equity 542.93 Million Baht

Finally, on behalf of the Board of Directors, I would like to express my gratitude to all shareholders, service recipients, customers, business partners, financial institutions, and patrons for their continuous trust and support of the Group's business. I also thank all executives and employees for performing their duties to the best of their abilities, working together to drive the organization to success. I ask everyone to be confident that the Board of Directors will perform its duties with full responsibility, considering the interests of all stakeholders, to ensure the organization's stable and sustainable growth.



Dr. Manit Teeratanantikarn Ms. Kanjana Pongpatanadecha

Chairman of the Board Chief Executive Officer

Vision

Drive the organization towards future growth with inspiration derived from the hopes of stakeholders (Inspiration From Hope)


Organizational Values


K Knowledge for life

T Transparent and verifiable

M Authentic in words and deeds, tangible

S Committed to sustainability


H Kind-hearted and generous

O Upholding commitments

P Adhering to operational standards

E Empathy

Objectives

Mission

• The company will operate its business efficiently in a lean and balanced manner (Fit & Firm).

• Collaborate to achieve shared success (Fighting & Victory).

• Develop new innovations for business advancement (Find the New Innovation).

• Generate returns in economic, social, and environmental aspects (Fertilization of Finance & Non-Finance).

Goals

The company's ultimate goal in conducting business is to enhance organizational value, consider the interests of all stakeholders, and generate sustainable long-term returns for shareholders.

Business Strategies

In preparing the business plan for the next three years, the Group considers the business environment and trends, including economic conditions, society, technology, laws, and government policies. Additionally, internal factors such as strengths, weaknesses, opportunities, risks, success factors, and critical issues requiring urgent action are also considered. The management will use these factors to determine the company's direction and the strategies of its core business lines (Core Business Strategy) to align with the company's vision. In implementing its strategies, the Group focuses on being a leader in providing comprehensive hemodialysis services and earning customer trust, under the certification of relevant regulatory bodies, to ensure the safety of chronic kidney disease patients' lives and to make the Group recognized and trusted.

from customers continuously, both in terms of quality and service standards. For the strategic plan in 2025 of

the Group will focus on the following issues:


1) Pricing Strategy (Price)


Medical Services at Reasonable Rates Supported by Government Health Welfare Programs (Good Value for Services)

The Group focuses on providing safe and efficient hemodialysis services at appropriate and cost-effective service or treatment fees. The Group charges hemodialysis service fees at the same rate as patients receive benefits from government health welfare programs, without any additional charges to patients, except for services using high-efficiency hemodialysis technology (OL-HDF) machines. For these, government health welfare programs, namely the Social Security Office and the National Health Security Office (NHSO), have a service fee rate of 1,500 Baht per session, and the Comptroller General's Department has a rate of 2,000 Baht per session. Additionally, the Group charges appropriate service rates for some patients who do not receive such benefits. Consequently, the Group is a primary choice for both patients covered by government health welfare programs and those not covered. Furthermore, in the future, the Group plans to expand its services to private hospitals and patient groups seeking special services, such as private hemodialysis rooms.

Furthermore, the Group benefits from various government health welfare programs, such as funding support for chronic patient services from the National Health Security Office (NHSO), which enables all eligible chronic kidney disease patients to jointly decide with their doctors to choose hemodialysis as their treatment method. This encourages a greater number of patients to utilize the Group's services.


2) Product and Service Strategy (Products & Services)

One-stop Services

The Group is a leader in providing comprehensive hemodialysis services, encompassing both the business of hemodialysis centers distributed across all regions of Thailand, services related to purified water production systems for hemodialysis and system maintenance, design and decoration services, and the distribution of medical equipment for hemodialysis centers, as well as the production and distribution of dialysate. This offers customers a variety of product and service options, enabling them to meet their needs comprehensively (One-stop Service) in a single instance. The Group thus has an advantage over other competitors in the market. Furthermore, it helps achieve economies of scale by sharing certain resources, such as saving personnel costs in service provision. This results in the Group having a cost advantage over competitors and being able to manage costs efficiently. Additionally, for some existing customers who use only one service from the Group, the Group can offer a wider range of comprehensive services, allowing the Group to expand its business more rapidly.


3) Distribution and Channel Strategy (Place)

Expansion of Hemodialysis Service Center

The Group is a leader in providing comprehensive hemodialysis services that comply with the standards of the Ministry of Public Health and the Nephrology Society of Thailand, in accordance with the recommendations for hemodialysis practice B.E. 2557 (2014). It has hemodialysis centers distributed across all regions nationwide. Currently, the Group has a total of 548 hemodialysis machines and 39 hemodialysis facilities, including both stand-alone hemodialysis clinics and outsourced hemodialysis units in hospitals, to facilitate customers and to increase the Group's recognition in each region. Regarding the production and distribution of dialysate, the Group has 1 distribution centers, which also reduces the cost of delivering dialysate and other products. This expands sales channels and facilitates kidney disease patients and both public and private hospital clients, as well as building the Group's image and enhancing operational efficiency to meet the increasing demand from kidney disease patients each year. Furthermore, the Group has expanded its engineering service channels, enabling rapid service delivery.


4) Sales Promotion Strategy

Excellence in Service Quality (Quality Excellence)

The Group is committed to maintaining its leadership in hemodialysis-related services and service quality in the long term. It has a team of qualified engineers, doctors, and hemodialysis nurses with specialized skills and expertise to ensure strict adherence to safety and service quality standards set by the Ministry of Public Health and the Nephrology Society of Thailand, in accordance with the recommendations for hemodialysis practice B.E. 2557 (2014) and the standards of the Sub-committee for Certification of Hemodialysis Treatment Standards (TRT). Furthermore, the Group emphasizes continuous training and development of its personnel to foster awareness of quality, standards, and customer satisfaction, as well as to constantly monitor new developments in medical technology and equipment. This enables the Group to offer high-quality services and enhance its service capabilities. Additionally, the dialysate produced by the Group is certified with Good Manufacturing Practice (GMP) quality standards, Quality Management System (QMS) ISO 9001:2015, and Quality Management System for Medical Devices ISO 13485:2016, which are systems used to manage processes to achieve products or services that meet customer requirements. The company has also received accreditation from the Joint Commission International (JCI) from the United States, awarded to healthcare facilities that comply with international standards and requirements for patient safety and comprehensive patient care, specifically for its hemodialysis unit at Vichaiyut Hospital.


After-Sales Service and Good System Maintenance (Preventive Maintenance Services)


Regarding services with product warranties and preventive maintenance services, the Group prioritizes after-sales customer service to ensure maximum satisfaction and meet customer needs. The Group has a team of technicians capable of providing services at all branches nationwide, and also maintains a schedule for visiting customer groups at various branches or hospitals to regularly check system operations. This ensures customers receive excellent after-sales service and fosters long-term relationships, while also creating opportunities to introduce new products and services to customers in the future.


5) Credibility Building Strategy

Experience and Trust from Customers (Experience and Trust)

The Group is managed by executives who are specialized hemodialysis nurses with over 15 years of experience in providing hemodialysis services. This enables quick decision-making and responsiveness to customer needs, leading to the Group's widespread recognition in the hemodialysis industry and the expansion of its branches to cover most areas of the country. Furthermore, the Group has earned the trust of public hospital clients, with service contracts renewed for over 5 years. Additionally, the company's subsidiaries possess expertise and experience related to purified water production systems for hemodialysis for over 20 years, and they design and decorate hemodialysis centers to recognized standards. This allows the Group to provide high-quality services that meet customer needs, adhering to national and international standards.


6) Strategy for Building Good Relationships with Business Partners

Given that key factors influencing the Group's business success are service trust and quality, the Group must gain confidence from public and private hospitals, kidney disease patients, nephrologists, and business partners. Therefore, the Group implements strategies to build strong relationships with these groups, which are considered key business partners, to foster support for the Group's business operations, such as customer referrals, medical information exchange, and marketing.

Material Changes & Developments

Material Changes & Developments

YearDescription
1,991

• Irving Corporation Limited ("IRV"), which is a subsidiary (currently 99.99% owned by the company), was registered and established on December 18, 1991, with an initial registered capital of 1.00 million Baht, divided into 10,000 ordinary shares with a par value of 100.00 Baht per share. It was founded by the Techakasem family group to operate a business in good water treatment systems (soft water or pure water) for industrial customers.

1,998

• Irving Corporation Co., Ltd. “IRV” increased its registered capital from 1.00 million Baht to 5.00 million Baht by issuing and offering 40,000 new ordinary shares with a par value of 100.00 Baht per share, to be used for business expansion.

2,002

• Irving Corporation Co., Ltd. "IRV" registered a capital increase from 5.00 million baht to 15.00 million baht through the issuance and offering of 100,000 new ordinary shares, with a par value of 100.00 baht per share. This capital will be utilized for business expansion and to commence operations in the purified water production system business for hemodialysis machines, including preventive maintenance services.

2,010

• Filter Vision Public Company Limited ("FVC") acquired Irving Corporation Limited ("IRV") by increasing capital and investing in the purchase of ordinary shares of Irving Corporation Limited ("IRV") from the Techakasem family group, which is the same shareholder group as the major shareholders of Filter Vision Public Company Limited ("FVC"), to restructure the business of Filter Vision Public Company Limited ("FVC") group in preparation for listing on the Stock Exchange of Thailand. The transaction price was based on the book value according to the financial statements of Filter Vision Public Company Limited ("FVC") and Irving Corporation Limited ("IRV") as of June 30, 2010. Following this transaction, Filter Vision Public Company Limited ("FVC") holds 99.99% of the paid-up registered capital in Irving Corporation Limited ("IRV").


• Irving Corporation Limited ("IRV") commenced research and development, including testing concentrated products for hemodialysis (dialysate solution).

2,011

• Irving Corporation Co., Ltd. (“IRV”) commenced its business in the design and fitting out of specialized dialysis units for nephrology clinics.

2,013

• Filter Vision Company Limited ("FVC") was registered as a company on the Stock Exchange of Thailand, with the ordinary shares of Filter Vision Public Company Limited ("FVC") being approved as a listed security on the Market for Alternative Investment (mai).

2,015

• KT Medical Services Co., Ltd. ("KTMS") was registered and established on June 5, 2015, with an initial registered capital of 10.00 million Baht, divided into 100,000 ordinary shares with a par value of 100.00 Baht per share. It was founded by Filter Vision Public Company Limited ("FVC") and the Techakasem family group, holding 70% and 25% of the shares, respectively, to operate a business providing hemodialysis services.


• Medical Vision Co., Ltd. ("MV"), which is a subsidiary of the company (the company currently holds 99.99% of the shares), was registered and established on July 10, 2015, with an initial registered capital of 10.00 million Baht, divided into 100,000 ordinary shares with a par value of 100.00 Baht per share. It was founded by Filter Vision Public Company Limited ("FVC") and the Techakasem family group, holding 75% and 15% of the shares, respectively, to operate a business in designing, installing, and providing preventive maintenance services for pneumatic tube systems for medical specimens.

2,017

• KT Medical Services Co., Ltd. ("KTMS") registered an increase in capital from 10.00 million Baht to 40.00 million Baht by issuing and offering 300,000 additional ordinary shares with a par value of 100.00 Baht per share. These shares were allocated to existing shareholders on a pro-rata basis (RO), with some shareholders waiving their rights. This resulted in Filter Vision Public Company Limited ("FVC") and the Techakasem family group holding shares in proportions of 70 percent and 25 percent, respectively. KT Medical Services Co., Ltd. ("KTMS") utilized the proceeds from this capital increase to expand its business by opening hemodialysis services in the form of dialysis units.

2,020

• KT Medical Services Co., Ltd. ("KTMS") registered an increase in capital from 40.00 million Baht to 55.43 million Baht by issuing and offering 154,317 new ordinary shares with a par value of 100.00 Baht per share for the restructuring of the company and its subsidiaries (collectively referred to as "the Group") and to enhance business potential.



• The Group has undertaken a restructuring to prepare for listing on the Stock Exchange of Thailand, resulting in KT Medical Services Co., Ltd. ("KTMS") acquiring a major stake in Irving Corporation Co., Ltd. ("IRV") and Medical Vision Co., Ltd. ("MV"), holding 99.99 percent of the shares.

2,021

• KT Medical Service Co., Ltd. ("KTMS") registered an increase in its registered capital from 55.43 million baht to 111.68 million baht, divided into 562,500 ordinary shares with a par value of 100.00 baht per share, allocated to existing shareholders proportionally (RO) and to private placement investors (PP).

2,022

• The Annual General Meeting of Shareholders for 2022, held on April 29, 2022, of KT Medical Services Company Limited (“KTMS”) resolved as follows:

1) Approved the conversion from a limited company to a public limited company.

2) Changed the par value from 100.00 Baht per share to 0.50 Baht per share.

3) Increased the registered capital by 38,318,300 Baht from 111,681,700 Baht to 150,000,000 Baht by issuing 76,636,600 additional ordinary shares with a par value of 0.50 Baht per share for initial public offering (IPO).


• On December 16, 2022, the Company registered an increase in its paid-up capital from 111,681,700 Baht with 223,363,400 shares to a total of 150,000,000 Baht with 300,000,000 shares at a par value of 0.50 Baht per share. It also raised funds through an initial public offering (IPO) of 76,636,600 additional ordinary shares with a par value of 0.50 Baht per share, setting the IPO offering price at 3.10 Baht per share.


• On December 23, 2022, KT Medical Services Public Company Limited listed its shares on the Stock Exchange of Thailand as a listed security on the MAI (Market for Alternative Investment) under the ticker symbol “KTMS”, which is the number one leader in providing hemodialysis services.


• Nephro Vision Company Limited (“NEP”), a subsidiary of the Company (currently 85% held by the Company), was registered and established on May 20, 2022, with an initial registered capital of 10.00 million Baht, divided into 100,000 ordinary shares, with a par value of 100.00 Baht per share. It was founded by KT Medical Services Public Company Limited (“KTMS”) and a group of nephrologists, holding 85% and 15% of the shares, respectively, to operate the business of providing hemodialysis services and medical services.

2,023

• The Annual General Meeting of Shareholders for 2023, held on April 26, 2023, of KT Medical Services Company Limited ("KTMS") resolved as follows:

1) Approved the payment of dividends from the Company's operating results for the year 2022 at a rate of 0.0327 Baht per share, totaling 9.80 million Baht, to the Company's shareholders, with the dividend payment scheduled for May 25, 2023.


• KT Medical Services Public Company Limited ("KTMS") increased its investment in a subsidiary by acquiring additional shares in Nephro Vision Company Limited, totaling 270,000 shares worth 27 million Baht. The Company's shareholding proportion is 88.75 percent.


• Nephro Vision Company Limited ("NEP"), a subsidiary of the Company, purchased land in Lamphun Province to establish a specialized hemodialysis medical clinic.


• Irving Corporation Limited ("IRV"), a subsidiary of the Company, purchased land in Pathum Thani Province to construct a hemodialysis solution production plant.

2,024

• The Annual General Meeting of Shareholders for the year 2024, held on April 26, 2024, of KT Medical Services Company Limited ("KTMS") resolved as follows:

1) Approved the payment of dividends from the company's operating results for the year 2023 at a rate of 0.014 Baht per share, totaling 4.2 million Baht, to the company's shareholders, with the dividend payment scheduled for May 24, 2024.


• Irving Corporation Company Limited ("IRV"), a subsidiary of the company, increased its registered capital by 30 million Baht, from the original registered capital of 25 million Baht to 55 million Baht, through the issuance of 300,000 new ordinary shares with a par value of 100 Baht per share.

2,025
  • The Annual General Meeting of Shareholders for the year 2025, held on April 28, 2025, of KT Medical Service Company Limited (“KTMS”) resolved as follows:

    1. Approved the payment of dividends from the company's operating results for the year 2024 at a rate of 0.0233 Baht per share, totaling 6.98 million Baht, to the company's shareholders, with the dividend payment scheduled for May 26, 2025.

Use of Proceeds from Securities Offerings

Introduction

The Company offered new shares to the public for the first time for trading on the Stock Exchange of Thailand (IPO), totaling 76,636,600 shares, following the offering of the Company's ordinary shares at an offering price of Baht 3.10 per share. The offering period was December 7, 8, 9, 2022, and December 13, 14, 15, 2022, totaling Baht 237.57 million. After deducting underwriting and distribution fees for the share offering and other related expenses, the remaining amount was Baht 230.45 million.


1. The utilization of proceeds from the capital increase aligns with the stated objectives. (Refer to the stock market news dated January 26, 2026, for the report on the utilization of capital increase proceeds from the initial public offering (IPO) as of December 31, 2025.)

Is There Money Raised from a Securities Offering Still to Report On?

No

Commitments Made in the Registration Statement

Are There Commitments or Conditions from an Offering or Listing?

No

Group Operating-Structure Policy

Description

The Company and its subsidiaries have a policy of employing professional executives who possess expertise in the subsidiaries' businesses and operate independently.


The Company has also appointed individuals to serve as directors of all three subsidiaries, with the objective of implementing policies and managing various aspects of the Company within the subsidiaries to achieve maximum efficiency.

Companies Where the Company Holds ≥10%

Companies (≥10% Holding)

Company NameAddressProvinceZip CodeTelephoneFaxBusiness TypeSecurity TypeSharesPaid-up Shares
Erving Corporation Co., Ltd.95 Ramintra 117, Ramintra Road, Min Buri District, BangkokBangkok1051002-518-0600Provision of design and installation services for water purification systems, titanium dialysis wastewater treatment systems, and system maintenance. Production and distribution of dialysis fluids. Design and decoration services for dialysis units. Design, assembly, and distribution of medical equipment for dialysis units.Common shares550,000550,000
Medical Vision Company Limited95 Ramintra 117 Road, Ramintra, Min Buri District, BangkokBangkok1051002-517-0134-5-Business operation, installation, and preventive maintenance services for Pneumatic Tube Systems used for transporting specimens, medications, and medical materials.Common shares100,000100,000
Nefro Vision Company Limited95 Ramintra 117 Road, Ramintra, Min Buri, BangkokBangkok10510--Hemodialysis service businessCommon shares400,000400,000

Shareholders with Potential Conflict of Interest

Has Potential-Conflict Shareholder (Y/N)

No

Relationships Among Major Shareholders

Relationship Exists (Y/N)

No

Shareholders' Agreement

Agreement Exists (Y/N)

No

Shareholding Diagram (Group Structure)

Does the company hold shares in other companies?

Yes

Subsidiaries

Company NameJuristic Persons / Holders
Irving Corporation LimitedKT Medical Service Public Company Limited · Voting rights percent: 99.99 · Shareholding proportion percent: 99.99
Medical Vision Company LimitedKT Medical Service Public Company Limited · Voting rights percent: 99.99 · Shareholding proportion percent: 99.99
Nephro Vision Company LimitedKT Medical Service Public Company Limited · Voting rights percent: 88.75 · Shareholding proportion percent: 88.75

Income Structure

Introduction

The Group's revenue structure, classified by revenue type for the fiscal year ending December 31, 2022 to the fiscal year ending December 31, 2024, is summarized as follows:

Product / Service Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenue from operationsTotal revenue from operations704,721.16100597,686.69100456,732.22100
Hemodialysis 590,027.0483.72483,815.2180.95354,890.1577.7
Design and installation of pure water treatment system and service preventive maintenance 88,027.8512.4987,760.3314.6878,696.3917.23
Design and installation of pneumatic tube system of equipment for medical service 26,666.273.7826,111.154.3723,145.685.07
OtherOthers000000

Export Income

CategoryDescriptionThis YearThis Year %Last YearLast Year %2 Years Ago2 Years Ago %
Total revenueTotal revenue704,721.16100597,686.69100456,732.22100
DomesticDomestic704,721.16100597,686.69100456,732.22100
InternationalInternational000000

Other Income

Operating Other IncomeNon-Operating Other IncomeShare of Profit
1710 · As of year: 3666.33 · Description: Total other income · As of yesteryear: 4217.32 · As of year before yesteryear: 4852.41 · 1711 · As of year: 2267.91 · Description: Other income from operations · As of yesteryear: 1933.36 · As of year before yesteryear: 1826.621712 · As of year: 1398.42 · Description: Other income not from operations · As of yesteryear: 2283.96 · As of year before yesteryear: 3025.791713 · As of year: 0.0 · Description: Share of profit · As of yesteryear: 0.0 · As of year before yesteryear: 0.0

Product / Service Characteristics

Introduction

At present, the Group is one of the leading providers of hemodialysis services in Thailand. We are able to provide comprehensive and one-stop services. The information of products and services of the Group are detailed below:

Business Type

3114

Business Groups

Business GroupDescription
Hemodialysis treatment service

The company provides hemodialysis services, which is a type of kidney replacement therapy that removes waste and water from the blood of chronic kidney disease patients (patients). The company provides services strictly in accordance with the standards of the Ministry of Public Health and the Kidney Foundation of Thailand, in accordance with the recommendations for hemodialysis practice in 2014 and the standards of the subcommittee on certification of hemodialysis treatment standards (TRT).


However, the nephrologist will consider the initiation of renal replacement therapy for patients with chronic kidney disease by considering the symptoms and criteria of the patients, for example, patients with chronic kidney disease whose Estimated Glomerular Filtration Rate (eGFR) is less than or equal to 6 ml/min/1.73 m2 or patients with complications arising directly from chronic kidney disease that do not respond to supportive treatment such as hyperhydration until having a heart attack or uncontrolled high blood pressure, abnormal mineral levels or have severe acidosis and decreased consciousness or convulsions from renal failure, etc. The choice of renal replacement therapy will be considered altogether between Nephrologist, patient and patient’s relatives including the right to treat the patients for suitability and to provide the best treatment outcome for each patient. The hospitals providing hemodialysis services of the Company are divided into 2 forms as follows:


1) Clinic or Stand-Alone

The company will open a specialized clinic in hemodialysis medicine. It is a hemodialysis facility that must be licensed to operate a medical facility by the Ministry of Public Health or the Provincial Health Office and certified by the Subcommittee on Accreditation of Hemodialysis Treatment (TRT). This clinic specializes in hemodialysis medicine. The Company is an investor in land, buildings, or provides premises for rent, operation and procurement of all equipment itself. In addition, the Group will design and decorate the hemodialysis unit. design Install a water purification system for hemodialysis. Provide a team of doctors specialized in hemodialysis. The Group must have a system to transfer and refer emergency patients to hospitals that offer hemodialysis services so that patients can receive continuous care. And there must be an infection control system in accordance with infection control standards.


2) Dialysis Unit or Outsource

The company will be a service provider by opening a hemodialysis unit to serve hemodialysis centers in public hospitals. The Company will participate in E-bidding procurement by public hospitals and must comply with the Public Procurement and Supply Management Act B.E. 2560 (2017). Decorate the hemodialysis unit in the area provided by the government hospital. Install a water purification system for hemodialysis. Provide a team of doctors specialized in hemodialysis. Hemodialysis nursing team and all related personnel to comply with the standard certification from the Subcommittee on Accreditation of Hemodialysis Treatment (TRT)


Hemodialysis units in public hospitals provide services to patients with chronic kidney disease according to rights from public health welfare programs. For hemodialysis, the company will charge hemodialysis to the contracting hospital. consist Rights of the National Health Security Agency (NHSO) Service fee per time 1,500 baht Medical welfare entitlement Civil Servant (Comptroller General's Department) Service fee per time 2,000 baht Rights of Local Government Organizations (OPP) and Rights of Social Security Office (SSO) The service fee per time is 1,500 baht, including services for patients with chronic kidney disease who pay in cash.


Standards related to hemodialysis services

1) Nephrology Association of Thailand Standards

1.1) Dialysis Practice Recommendations by Hemodialysis Machine 2014. The Nephrology Association of Thailand has prepared recommendations for hemodialysis practice. To be used as a guideline for hemodialysis services. To be used as a guideline for hemodialysis services. To promote efficiency and bring maximum benefits to patients, such as procedures for preparing blood vessels for use in hemodialysis. Hemodialysis machine and filter Quality of purified water system Procedures for providing hemodialysis services, and infection control and prevention, etc.

1.2) Guidelines on Preparation of Purified Water for Hemodialysis Year 2021 The Nephrology Association of Thailand has established guidelines on Preparation of purified water for hemodialysis This is a standard related to design services. Installation of pure water production system for hemodialysis and system maintenance, including hemodialysis standards. The standards can be summarized as follows:

• Pure water production systems, such as the design of pure water supply systems, need to take into account the prevention of infection from forming easily. (dead end) so that there is no standing water in the system. The materials used to make pipes and water supply pumps must be rust-free. The inner surface is smooth and resistant to disinfection methods.

• Quality control of pure water system standards, both in terms of installation of pure water systems, in terms of system installation and maintenance of pure water supply systems. Hemodialysis clinics and hemodialysis units are required to regularly send samples of pure water to confirm the quality of the pure water and the equipment used to produce the pure water, such as chemical contaminant detection, bacterial count, etc.


2) Hemodialysis treatment standard Year 2014 by the Subcommittee on Accreditation of Hemodialysis Treatment (TRT) Royal College of Physicians of Thailand

Subcommittee on Accreditation of Hemodialysis Treatment (TRT) Royal College of Physicians of Thailand There are criteria for certification of hemodialysis treatment. It consists of 11 components, including medical facilities, hemodialysis units. Services, personnel, facilities, hemodialysis machines and filters, purified water production systems. Life-saving equipment and medications, records and operational manuals The Hemodialysis Treatment Accreditation Subcommittee (TRT) will conduct two standard assurance audits with all components of the hemodialysis unit every 6 months and will renew the certification in 2 years and every 4 years, respectively.


3) Standards for hemodialysis services in medical institutions as announced by the Ministry of Public Health.

It is a standard of the Ministry of Public Health that dialysis units in government hospitals must comply with. It specifies the duties and responsibilities of those responsible for providing dialysis services, such as the qualifications of medical professionals, the proportion of nurses (not less than 1 person per 4 patients receiving dialysis), the arrangement of the place, environment, and facilities for dialysis, etc.


The Company provides 2 types of Hemodialysis:

1) Conventional hemodialysis (HD)

is the standard method for dialysis relying on the diffusion process to exchange waste products between blood and hemodialysis concentrate. Therefore, small molecule waste, excess water and some drugs can be removed.

2) Online Hemodiafiltration (OL-HDF)

is a dialysis machine developed with 2 processes, Diffusion and Convection. This process is to remove small and large molecules of waste more than conventional hemodialysis. Therefore, it is more effective than normal hemodialysis, especially for patients with diabetes. The allergic reactions in patients who are allergic to dialyzer can be reduced. For the OL-HDF type, the Company will charge a higher rate than normal hemodialysis. The service is charged from 1,800 to 2,000 baht per time.

Design and installation service of pure water production system for hemodialysis and system maintenance

The Group is a contractor for water purification systems for dialysis units in hospitals and clinics from the design, installation and preventive maintenance of the water purification system for hemodialysis and wastewater treatment system. The team of engineers with knowledge and expertise of the Group will design a water system that is suitable for that medical facility and to meet the standards related to the water system for hemodialysis. Then, the engineering team will procure equipment, assemble and install related materials and equipment according to the specified designs. The warranty for preventive maintenance products and services is for at least 1 year according to the terms of the contract. The customers can call for emergency services 24 hours a day having a team of technicians from the Group to provide service. The customer may extend the contract by paying an additional fee for the provision of preventive maintenance services.


In addition, the Group also sells services related to water purification systems in the form of financial leases. It is sold in installments to serve customers who have operational potential but have limited investment or budget. It also increases the choice of receiving services to meet the needs of customers even more.


1) Pure water production system for hemodialysis

The Group provides design, installation and preventive maintenance services for water purification system for hemodialysis. In general, pure water is water that has passed through the reverse osmosis (RO) process, both in direct feed and indirect feed. However, the production capacity depends on the number of Hemodialysis and the valve of the dialyzer reused bath. The design of the Group will be in accordance with the requirements and standards of the Subcommittee on Certification of Hemodialysis Treatment Standards.


2) Wastewater treatment system for hemodialysis units and hemodialysis clinics

The Group provides design, installation and preventive maintenance services for wastewater treatment systems of hemodialysis units and medical clinics. This is in accordance with the notification of the Ministry of Natural Resources and Environment for a specialized hemodialysis clinic and the requirements of the Ministry of Public Health for hemodialysis units.

Production and distribution of hemodialysis concentrate

The Group of companies produces and distributes hemodyalysis concentrate to hemodialysis hospitals for both government hospital customers and private customers. The produced hemodialysis concentrate are certified by GMP production quality standards and international organization standards ISO 13485: 2016 and ISO9001: 2015.


The production of hemodialysis concentrate of the Company can be divided into 2 types, namely acidic hemodialysis (Mc-A) and concentrated Bicarbonate hemodialysis (Mc-B) with production quantities and mixes as ordered by nephrologists depending on each patient. The Company has an in-house laboratory department and an outsourcing company to test the quality of hemodialysis concentrate to meet the required standards before distribution.

Design and decoration services of hemodialysis for hospitals

The Group has a team of engineers with specific expertise in designing and decorating the hemodialysis hospitals for hemodialysis units in government hospitals and hemodialysis clinics to meet the standards of the Ministry of Public Health and the Kidney Association of Thailand. There will be an external sub-contractor responsible for the construction. However, the Group will provide a guarantee for the work with the employer for not less than 1 year according to the terms of the contract. The external sub-contractor will ensure the work and guarantee all construction.

Design, assembly and distribution of medical equipment for hemodialysis hospitals

The Group provides design, assembly and installation of medical equipment for hemodialysis hospitals. Most of them are purchased from medical device dealers to be assembled and installed for customers, such as XION machine, dialyzer cabinet, dialyzer hanger, and a reused blood, etc. Some are the distribution of medical equipment for hemodialysis such as consumables for hemodialysis, etc.

Design and installation service of Pneumatic Tube System

The Group operates import, design and installation of Pneumatic Tube System which is designed to suit the area and usage according to customer needs for various hospitals, Central Paying Unit, medical laboratory, emergency intensive care unit, emergency unit and patient dormitories. The Group is a distributor from Telecom Bedrijfscommunicate B.V., Netherlands, which is one of the companies laying Pneumatic Tube System with more than 30 years of experience and expertise in system implementation. The systems have been installed for customers in more than 40 countries. Examples of transport items include drugs, blood collection tubes, documents, and items that can be packed in a bobbin weighing not exceeding 1 to 2.5 kilograms, etc.

In addition, the Group also provides a guarantee for products and services for system maintenance for at least 1 year according to the agreement. There is an emergency service that customers can contact to report problems 24 hours a day and a team of technicians from the Group will inspect and fix the system.

Research & Development

Has R&D Policy (Y/N)

Yes

Introduction

The Group places great emphasis on research and development of products and services continuously. The company is committed to developing hemodialysis services and the production process of hemodialysis solutions that are promising and very important for patients with chronic kidney disease. For hemodialysis The Group is committed to improving the quality of the pure water production system for hemodialysis and developing the potential of information system technology for air duct systems to enhance the quality and service standards. and to accommodate the larger demand. In addition, the Group has researched and developed skin creams for patients with chronic kidney disease to help relieve itching due to systemic changes in the body from the symptoms of the disease.

R&D Cost — Description

The Company has a research and development project for products, raw materials, packaging, production processes, and tools for research and analysis of the quality of dialysis products, with related costs for developing dialysis formulas.

R&D Cost — Label

Research and development (R&D) expenses over the past 3 years (Million Baht)

R&D Cost — This Year

0.0

R&D Cost — Last Year

0.0

R&D Cost — 2 Years Ago

0.0

Assets Used in the Business

Permanent Assets — Description

Assets used in business operations


As of December 31, 2024, the Group has the main assets used in business operations as follows:


Fixed assets used in business operations


The details of fixed assets of the Group used in important business operations can be summarized as follows:

Intangible Assets — Description

The details of the Group’s intangible assets used in business operations are computer programs and software with net book value as of December 31, 2024 equal to 1.70 million baht.

Has Subsidiaries Investment Policy (Y/N)

Yes

Subsidiaries Investment Policy — Description

The Company has a policy to invest in businesses that are related, similar, or beneficial to including supporting the business operations of the Company and its subsidiaries to strengthen competitiveness and create sustainable value for the business. The Board of Directors has a policy to appoint representatives with appropriate qualifications and experiences to hold directorships or executive positions in subsidiaries in proportion to the Company’s shareholding to supervise the management of subsidiaries in accordance with the policies, goals, work plans, strategies and budgets of the Company. In order to monitor the operations of subsidiaries, the Board of Directors requires subsidiaries to report operating results to the Executive Board and the Board of Directors at least once a quarter.

Marketing Policy & Competition

Reporting Mode

3117

Marketing Policy (Overall)

For providing hemodialysis service in the hemodialysis unit of the hospital, the Group has a Cost-plus Pricing policy. The government hospitals will pay service fees to the Group according to the agreed rate.


For hemodialysis services in the clinic, the service rates for hemodialysis by conventional hemodialysis are in accordance with government agencies (Social Security Office and the National Health Security Office (NHSO) equal to 1,500 baht per time) and service fees for OL-HDF equal to 1,800 to 2,000 baht per time.


For other services, the Group has a pricing policy that is competitive in the business. The Cost-plus Pricing policy consists of prices of products and accessories used for assembly and installation, complexity and scope of work and the number of personnel required for operation. We include considering the history and relationship with customers who have had transactions in the past. The Group will regularly search for market price information to be aware of the situation and the possibility of selling and bidding for the ability to always make competitive prices and bids.


Characteristics of customers and target groups


The Group has been in the business related to hemodialysis services for almost 10 years and has been trusted by customers in using the service continuously. The characteristics of customers and target groups can be divided into 2 main groups according to the nature of the services provided by the Group, namely 1) customers from providing hemodialysis services and 2) customers from providing other services and distribution. There are preliminary details as follows.


1. Customers from Hemodialysis Service


The group of customers from hemodialysis service can be classified into 3 groups: 1) Government hospital customers, 2) Government health welfare program customers which consists of the National Health Security Office (NHSO) and the Social Security Office; and 3) customers who pay in cash.


For the services of the Group provided to customers of government hospitals, the Group will directly receive service fees from government hospital customers. However, for the service provided at the hemodialysis clinic, the Group will receive service fees from the customers of the government health welfare program and customers who pay for services in cash.


1) Government hospital customers

The Group provides services to government hospital customers covering almost every region. This is because most government hospitals need teams and personnel with specific expertise who can manage the hemodialysis unit and provide hemodialysis services. From the demand for services from a large number of patients with chronic kidney disease, the government hospitals therefore open for outsiders to manage the hemodialysis unit in the form of a contract for hemodialysis services for patients.


The government hospital customers will pay service fees to the Company at the agreed service rate. The government hospitals will collect money according to the rights from the patient’s government health welfare program consisting of the Social Security Office and the National Health Security Office (NHSO) equal to 1,500 baht per time and the Comptroller General’s Department equal to 2,000 baht per time. In addition, some groups of chronic kidney disease patients who are not eligible for the government health welfare program will pay the service fee to the government hospital in cash.


2) Customer groups of government health welfare projects

For the services of the Group at the Hemodialysis Clinic, the Group provides hemodialysis services for end-stage chronic kidney disease patients who are eligible for government health welfare programs, namely the National Health Security Office (NHSO) and the Social Security Office (PHS). Such government agency will pay the service fee to the Group at 1,500 baht per time.


3) Customers who pay in cash

Some chronic kidney disease patients who receive hemodialysis services at clinics that are not eligible for the government health welfare scheme will have to pay for their own medical expenses. The service fee is 1,500 baht per time. The Group’s target customers are patients with chronic kidney disease living in the area close to the Hemodialysis Clinic of the Group.


2. Customers from other services and distribution

Customers from other services and distribution include design and installation services of pure water production system for hemodialysis and system maintenance, production and distribution of hemodialysis concentrate, design and decoration service of hemodialysis hospitals, design, assembly and distribution of medical equipment for hemodialysis hospitals, design and installation service of Pneumatic Tube System. The customers can be classified into 2 groups, namely, government hospital customers and private customers. The details are as follows.


1) Government hospital customers

Generally, the Group recruits from government hospital customers for other services and distribution through the procurement system (Thai Government Procurement). The Group provides services to customers of government hospitals covering most areas of Thailand.


2) Private customers

The Group provides services related to hemodialysis, including design and installation of a pure water production system for hemodialysis and maintenance, design and decoration service system of hemodialysis hospital, distribution of hemodialysis concentrate, design, assembly and distribution of medical devices for hemodialysis facilities. Most of the private customers are the customers of the kidney dialysis clinic and dialysis units in private hospitals. The customers for the installation service of Pneumatic Tube System are private hospitals and various private clinics.


Distribution and distribution channels

1) Participating in the E-bidding

For hemodialysis service among government hospital customers, the Group will participate in the bidding for the contract for hemodialysis services with the electronic bidding method (E-bidding). The Group has divided sales personnel to be responsible for contacting government hospital customers especially. The Group can access information and participate in bidding through the E-Bidding system. The Group are obliged to carry out the tasks specified by the government hospitals in specific details according to the contract, such as installation and maintenance of pure water production systems, installation of hemodialysis machines and systems along with all kinds of equipment related to hemodialysis service, procurement of professional nurses as heads of the hemodialysis unit. For some hospitals, the head of the hemodialysis unit must be provided, etc.

For other services and distributions, the Group will participate in the bidding for services by means of electronic bidding (E-bidding). The Group has a sales team to meet with government hospital customers and follow up on the needs of the customers and relevant agencies to bring to the plan or a suitable service offering plan meets the needs of customers and presented to provide services that meet the needs or requirements according to government announcements. For customers in the government hospital group, it is necessary for the Group Companies to comply with the Government Procurement and Supplies Management Act B.E.2560. The Group must perform the operations of the government hospitals’ specifications mentioned in the employment contract, such as performing as designed, assembly and installation, etc., along with a product warranty and system maintenance for work related to pure water production systems, design and decoration.


2) Direct contact to the Company

The customers from government hospitals and private customers may contact directly through the Group. The Company’s executives have more than 15 years of experience in providing hemodialysis services. Besides, the past performance of the Group is in various hospitals and clinics that provides a wide range of services and complete range of hemodialysis services. As a result, the Group’s service was recommended to customers by word of mouth, which made the group well-known in the kidney dialysis industry and has a good relationship with both government hospital customers, private hospital and various private hemodialysis clinics including the medical team and a team of artificial kidney nurses giving the Group an opportunity to expand the customer base in offering a wider range of services.

3) Distribution through salespeople in search of business opportunities

For hemodialysis service, the Group is looking for an opportunity to expand branches of the Hemodialysis Clinic in order to be able to provide services to cover more areas of the country. The sales personnel who understand the hemodialysis service and the executives will find a potential location to open a new branch of the hemodialysis clinic. This includes analyzing the number of patients with chronic kidney disease in that area to always search for business opportunities. After that, the sales personnel and the administrative department will perform various permissions to open the clinic.

For other services and distribution, the sales personnel will be responsible for the presentation of services and distribution of products. The sales personnel will contact and make appointments with government hospital customers and direct private customers to study customer needs, presentation of information about products and services of the Group that are suitable for customers including coordination care and knowledge as requested by customers in order to be able to offer a full range of services to customers.

Industry & Competition (Overall)

Situation of patients with kidney disease in Thailand

Chronic kidney disease is the NCD with the highest growth in the loss of healthy years. Between 1991-2021, Thais lost 3.14 times more healthy years, higher than cancer and cardiovascular disease, which increased by 2 times and 1.8 times, respectively. In addition, in the fiscal year 2024, more than 1.13 million Thais suffered from chronic kidney disease. The main causes of the disease are food and drug consumption behavior, diabetes, high blood pressure, and smoking. In the past, Thailand has implemented preventive measures to prevent the number of patients from increasing, including treatment measures for peritoneal dialysis, hemodialysis, and kidney transplantation. On February 1, 2022, the government issued a policy allowing patients under the National Health Security Fund to choose their own dialysis method, instead of previously focusing on peritoneal dialysis as the first priority. This policy resulted in the number of patients with end-stage renal disease switching to hemodialysis services rapidly increasing by 88.75 percent within 1 year. There are many related issues that can be used as lessons for future policy formulation, including:

1) Medical personnel and dialysis service units are still insufficient for the increasing number of patients. Each hemodialysis session must be under the care of medical personnel, while there are still insufficient nephrologists and kidney specialist nurses.

2) Lack of equipment for providing end-stage renal disease services. In 2022, there were 11,613 dialysis machines, an increase of only 5.14 percent from 2021, which is very low compared to the number of service users, which has more than doubled.

3) Hemodialysis is not suitable for all chronic kidney disease patients. More than 5,000 end-stage renal disease patients who received hemodialysis services died within just 2 years, and this is expected to increase.

4) Peritoneal dialysis costs less than hemodialysis. From the budget calculations received by the NHSO, the cost of peritoneal dialysis is 140,000 - 150,000 baht per person per year. Lower than the cost of hemodialysis, which is approximately 160,000 - 170,000 baht per person per year, and

5) The government budget for end-stage renal disease treatment tends to increase continuously. The total expenditure for renal replacement therapy for all rights in fiscal year 2019 was 14,181 million baht, increasing to 19,012 million baht in fiscal year 2022.

In addition, the actual government budget for end-stage renal disease treatment is still higher than the target every year.


As a result of the above actions, on November 4, 2024, the Fund has a guideline to bring back the policy of peritoneal dialysis as the first option to increase the proportion of peritoneal dialysis services to at least 50 percent of new chronic kidney disease patients who need dialysis. At the same time, the lessons learned above also reflect that in the next phase, the government may apply the concept of the zero-based budgeting method, which considers allocating budgets based on necessity and the situation that needs to be implemented, regardless of the budget that was previously allocated. This will help the state health insurance system that needs to request budget support to consider value, efficiency, and appropriateness, as well as prioritize operations, including giving more importance to health promotion, disease surveillance, and prevention, especially behavioral changes, both in terms of consumption, physical activities, and appropriate blood sugar/blood pressure measurement and control.


Industry trends

The Group operates hemodialysis services and water purification systems for hemodialysis, as well as sales and services related to medicine. With international quality and standards for both public hospital customers and private customers, the Company analyzes factors that may affect the Group's future performance from Thailand's economic growth prospects The Group's business growth trends include hemodialysis services. Design Services Business Installation of a pure water production system for hemodialysis and system maintenance. Production and distribution of hemodialysis solutions The business of designing, assembling and distributing medical devices for hemodialysis hospitals and the business of providing design and installation services for air duct equipment. This includes government policy announcements that affect the Group's business operations.


Business overview of hemodialysis service

The Group provides renal replacement therapy services through hemodialysis. It removes waste and water from the blood of chronic kidney disease patients with very low glomerular filtration rates or patients with complications directly arising from chronic kidney disease. The hospitals providing hemodialysis services in Thailand can be divided into 2 types as follows:

1) Government hemodialysis hospitals:

For the hemodialysis unit in a government hospital, the government hospital will hire a company to manage the hemodialysis unit of that hospital by means of electronic bidding (E-bidding) according to the Government Procurement and Supplies Management Act B.E.2560. The contracted company will have to design and decorate the hemodialysis unit in the hospital along with supplying equipment and systems for producing pure water for hemodialysis in order to meet the standards from the Subcommittee on Certification of Hemodialysis Treatment Standards. The government hemodialysis hospital provides services to patients with chronic kidney disease according to the right from Government health welfare program which consists of universal health insurance rights, social security rights, civil servant medical welfare, State Enterprise Medical Welfare, life insurance rights, and the right to receive treatment from various charitable organizations including providing services to patients who pay in cash.

2) Private hemodialysis hospitals:

Private hemodialysis hospitals consist of hemodialysis units in private hospitals and kidney dialysis specialist clinics in order to support the continuous expansion of the patient population with chronic kidney disease. This must be managed and maintained in accordance with the standards from the Subcommittee on Certification of Hemodialysis Treatment Standards. The private hemodialysis medical centers provide services for patients with chronic kidney disease according to rights from health insurance rights, the social security rights, life insurance rights, and the right to receive treatment from various charitable organizations including providing services to patients who pay in cash.


Currently, there are 3 methods of dialysis:

1) Hemodialysis: This method takes the blood of patients with end-stage chronic kidney disease who have accumulated waste through the blood purifier and returns it to the patient's body.

2) Peritoneal dialysis: This method can be done at home by inserting dialysis solution into the abdomen and replacing 2 liters of peritoneal dialysis solution 4 to 6 times a day continuously 24 hours a day.

3) Kidney Transplantation, which is the best treatment for chronic kidney failure.


The continuous increase in chronic kidney disease patients in Thailand is mainly due to

1) diabetes and hypertension. This causes other chronic complications, including renal degeneration, with 40% of diabetic patients found to have renal dysfunction and kidney function will gradually deteriorate.

2) Aging: As we age, kidney function gradually declines and deteriorates with age.

3) The dietary behaviors are such as eating very salty, very sweet or spicy foods, drinking too little water including taking certain drugs continuously.

4) For hereditary, if someone in the family is sick with one of the diseases in the group of renal dysfunctions, it will cause a risk of kidney disease as well.


1) Trends of Diabetes and Hypertension Patients

According to the information from the Kidney Association of Thailand, hypertension and diabetes are the leading causes of chronic kidney disease representing 42.30% and 41.50% of the causes of chronic kidney disease receiving renal replacement therapy of patients in 2020. If the level of high blood pressure is very high, it may cause negative effects on various organs, such as increasing the incidence of heart disease, kidney disease and stroke, etc. Apart from the high blood pressure, diabetes is another major cause of patients undergoing renal replacement therapy. Diabetes is a disease caused by abnormalities in the control of sugar levels in the body causing blood sugar to be higher than normal due to pancreatic insulin deficiency or insulin resistance. It makes the tissue unable to use the sugar. Hyperglycemia results in abnormalities of both small and large blood vessels resulting in complications of diabetes. Chronic kidney failure is one complication which occurs in up to 40% of patients with diabetes.

2) Increase in the proportion of the elderly to the total population in Thailand

According to the report on the situation of Thai Older Persons in 2020 prepared by the Foundation of Thai Gerontology Research and Development Institute, Thai population age structure was found to change drastically in the past half century from a younger population to become an aging population.

National Economic and Social Development Board ("NESDB") Thailand's population is expected to increase from about 65 million in 2021 to about 67.1 million in 2030 and will decrease to about 65.4 million in 2040. Currently, the Thai population is increasing at a slower pace and in the next 20 years, there is a possibility that the rate of increase in the Thai population will reach a negative level. It can be seen from the population projection diagram by age group of Thailand that in 2021, Thailand has only 12.1 million people aged 60 and over, or 15.8% of the total population, while the projected elderly population of 2040 has roughly doubled to 20.5 million. This will result in Thailand becoming an ageing society. According to the guidelines, there are more than 20% of the country's population aged 60 years and over. In addition, with progressive medical policies as well as increasing interest in public health care in general, life expectancy is increasing. Everything. The increase in the number and proportion of the elderly population will result in greater demand for medical services. Because the elderly are prone to illness, they may have complications and need continuous medical treatment.

3) Consumption behavior of Thai people at risk of kidney disease

The network to reduce salt consumption, Thai Health Promotion Foundation (ThaiHealth) and the Kidney Disease Society of Thailand today published the results of a study from the Estimated dietary sodium intake in Thailand: A nation wide population survey with 24 hour urine collections conducted in collaboration with the World Health Organization (WHO) published in the Journal of Clinical Hypertension on Feb. 8. January 2021. It was found that the average sodium consumption of Thai people is 3,636 milligrams per day. That is 1.8 teaspoons of salt, far more than the World Health Organization (WHO) recommended daily sodium limit of 2,000 milligrams per day. The excessive sodium intake increases the risk of hypertension, coronary heart disease and chronic kidney disease.

4) Hereditary

Some kidney diseases are hereditary. This may be from birth or gradually showing symptoms later, such as Polycystic Kidney Disease, a genetic disease that causes the presence of a large number of cysts in both kidneys and increasing in number. This causes the kidneys to gradually deteriorate leading to kidney failure and death. Therefore, if someone in the family has this disease, there is a high chance of getting this disease.


Financial support for chronic patients from the National Health Security Agency (NHSO)

Expenses for public health servicesList of services for patients with chronic kidney failure is an additional budget from medical services per capita. For those eligible for National Health Insurance It covers all types of expenses, medications, and related services for treatment, including: 1) peritoneal dialysis; Peritoneal Dialysis (PD), 2) Hemodialysis (HD), and 3) Hemodialysis. Kidney transplant surgery (KT) consists of surgery and immunosuppressive drugs after kidney transplantation (KTI). 1) In case of peritoneal dialysis. The NHS will support unlimited dialysis fluids and abdominal dialysis lines, including peritoneal dialysis service fee of 2,500 baht/month. The NHS is responsible for the cost of vein preparation, hemodialysis, and support for all EPO drugs, as well as the dialysis service fee of 1,500 baht per time. The NHS will be responsible for the cost of PPE for hemodialysis unit staff, with an actual payment of not more than 500 baht per kit and not more than 2 sets per patient.


Policy on assistance for hemodialysis services for chronic kidney failure patients who do not voluntarily receive peritoneal dialysis services.

Meeting of the National Health Security Committee (Board of NHSO) No. 1/2022 On January 6, 2022, a resolution was passed to approve the adjustment of the care system for patients with chronic kidney failure. Previously, at the beginning of the benefit for patients with chronic kidney failure. The NHS tries to get patients to use abdominal dialysis. This is a way patients can do it at home to ease the burden and reduce the number of staff they need to attend. Provided that if the patient does not wish to undergo abdominal dialysis and there is no indication that hemodialysis is required. The patient must pay by himself and will have to bear the cost of dialysis by himself at 1,500 baht per time. however Nowadays, the health system is more equipped to take care of patients with hemodialysis methods. Both human resource and equipment development make it easier to do than in the past. Board of Directors NSC. Therefore, it was resolved to approve the NHSO. Take care of expenses for patients with chronic kidney failure who do not wish to use abdominal dialysis. To provide flexibility and choice for patients with end-stage renal disease. It takes into account the needs and quality of services that patients will receive. Effective from February 1, 2022.


Policy to support SME entrepreneurs by increasing bidding opportunities for government projects

On September 1, 2020, the Ministerial Regulations specified the supplies and procurement methods that the government wants to promote or support (2nd revision) B.E.2563. It allows SMEs to enter the public procurement market even more. This is because the law stipulates that government agencies must procure goods or services from SMEs registered with OSMEP in the amount of not less than 30% of the procurement budget. SMEs are encouraged to compete with large entrepreneurs. The government agencies procuring through the E-Bidding system are required to procure from SMEs if the SMEs offer a higher price than the large entrepreneur who bid the lowest price by no more than 10%.

The Group has established Nephro Vision Company Limited together with 2 nephrologists in the proportion of 88.75%, 5.625% and 5.625% respectively, to support the growth of the Group’s dialysis service business. The Company operates hemodialysis business with a registered capital of 10 million baht. The establishment of NEP will mainly be a collaboration with a local kidney physician to make nephrologists feel a sense of co-ownership. NEP will also benefit from government SME support policies that can bid 10% higher than competitors in e-bidding, subject to sector rules. The government must employ more than 30% of the total employment from SMEs. This is an opportunity for SME entrepreneurs to bid for projects with the government sector.

Procurement of Products & Services

Reporting Mode

3117

Procurement (Overall)

Procurement of products and services of the Group

The Group has procedures for providing services to customers as follows:

1) Searching for business opportunities

The executives of the Group, the sales and marketing department will continue to explore business opportunities by providing a location for hemodialysis services both in the form of hemodialysis units in hospitals and clinics. The sales and marketing departments will constantly follow the notifications of the government hospitals to find business opportunities to participate in tenders with government hospitals.

2) Operations for hemodialysis units in hospitals and clinics

Hemodialysis unit in the hospitals

The Sales and Marketing Department will prepare the Tender Guarantee and E-bidding documents together with the Hemodialysis Operations Department who will set the price. The engineering department will visit the place to survey including the design of the hemodialysis unit according to relevant standards.

Hemodialysis Clinic

The Sales and Marketing, Hemodialysis Operation Department, and Medical Support Department will handle land purchases or making a lease of land and buildings for a kidney dialysis clinic.

3) Signing a contract with a customer for hemodialysis unit in a hospital

For the hemodialysis unit, once the Group has won the E-bidding, the Group’s sales and marketing department will prepare a letter of guarantee from the bank and coordinate with the contract signing with the customer. The duration of the service contract with the government hospital is on a year-to-year basis. Every contract prior to the submission of the proposal is always reviewed by an external legal advisor.

4) Preparation and setting up of the hospital system

The Medical Support Department will select sub-contractor for the construction of the clinic or decoration of the hemodialysis unit in accordance with the specified design and in accordance with relevant standards. The operation will be supervised by a team of engineers of the Group with expertise in the design and decoration of the hemodialysis unit. The Group also offers the installation of a water purification system for hemodialysis and maintenance of the system and procurement of hemodialysis concentrate. There will be hired companies in the group as operators.

For the provision of tools and equipment for hemodialysis service, the Group has a plan to purchase medical equipment and tools. We consider the plans to open new branches and estimate the number of patients who will receive services with the Group. This is consistent with the Company’s strategic plan. The administrative department and the warehouse will produce a report including the use of the Point of Sale (POS) system to manage recording service information from patient registration, patient appointment schedule, warehouse management and sending of information about product levels to the head office for procurement approval according to the table of approval authority of the Group. We purchase from domestic dealers with quality and international standards with insurance and maintenance services for consumables for use in hemodialysis. The Group purchases from local distributors. The purchase of all medical devices and equipment will be approved according to the approval authority table of the Group. In addition, the Group has prepared Approved Vendor List, compare prices, quality, delivery time, payment terms and product and service warranty including being reviewed annually in order for the group of companies to receive the best conditions and to enable the purchasing department to work more flexibly.


To provide a nephrologist for a hemodialysis unit operating in a government hospital or for a dialysis clinic, which is an important component before the dialysis service is opened, the process can be divided as follows:


In the case that the hospital has a regular nephrologist, the Group does not have to recruit additional nephrologists to work in the hemodialysis unit.


In the case that the hospital does not have a nephrologist on duty, the Group must recruit nephrologists to work in the hemodialysis unit according to the requirements specified in the Term of Reference or TOR.


In case of a hemodialysis clinic, the Group has to recruit a nephrologist for the clinic, which is one of the components in applying for a license to operate a clinic.


In the past, the Company has been able to continue recruiting nephrologists from the reputation and experience in providing hemodialysis services together with the good relationship between the Group and nephrologists in different areas.


For the recruitment of professional staffs including hemodialysis nurses, nursing assistant and patient helpers to meet the relevant standards, the recruitment of personnel of the Group will be checked for qualifications and professional documents that are correct and complete before accepting work in order to comply with the requirements of the Ministry of Public Health and the Thai Kidney Association, for example receiving a training course on specialized nurse in renal replacement therapy practice nursing (Hemodialysis) etc.


The Human Resources Department is responsible for recruiting employees through various channels, including the Group’s website, Social Media for Dialysis Nurses Group, and further recommendations from internal employees, etc. In addition, the Company’s executives have a good relationship with the group of nurses in that area. Therefore, it is another important channel to reach such personnel widely.


In addition, in order to develop personnel and maintain operational standards, the Group requires training for personnel in every department by conducting orientation for new employees. There is an annual employee training plan, such as advanced cardiopulmonary resuscitation (CPR), training courses on occupational safety, health and working environment, training on Infectious Control (IC) in the hemodialysis unit, prevention of infection in the hemodialysis unit, ISO9001 standard requirements, and knowledge training on hemodialysis products, purified water production system and Pneumatic Tube System, etc.


5) Implementation of relevant licenses and certifications of relevant standards

The Hemodialysis Operations Department will proceed with the Subcommittee on Certification of Hemodialysis Treatment Standards for hemodialysis units and clinics. The clinics can take the procedures for obtaining a license to operate a medical facility from the Ministry of Public Health or the Office of Provincial Public Health.


6) Implementation of hemodialysis service

The Hemodialysis Operations Department has a team of nurses and patient assistants who provide hemodialysis services along with close supervision throughout the service for the safety of patients.


7) Inspection of service quality and standards

The nursing team and the Hemodialysis Operations Department supervise the services to ensure compliance with relevant standards. The Subcommittee on Certification of Hemodialysis Treatment Standards will inspect the quality and relevant standards periodically for both the clinic and the hemodialysis unit in the hospital. For the hemodialysis unit in the hospital, the Group will take additional actions to meet the quality conditions and standards specified by each hospital.


Other services and distribution

1) Searching for business opportunities

The Company’s executives and the sales and marketing departments carry out marketing plans to expand the type of services to be complete. It is to expand the base and maintain relationship with customers. The sales and marketing departments will constantly follow government notifications to find business opportunities to participate in public hospital tenders.


2) Prepare a quotation or E-bidding documents (if any)

In case of preparing quotations for public hospital tenders, the sales and marketing department will examine the qualifications of the bidders according to the criteria set by the government hospital. The engineering and medical support department will conduct a site survey and design the project according to the customer’s needs and related standards in order to evaluate the price according to the Term of Reference or TOR prepared by the government hospital (E-Bidding). The Group has a sales and marketing department as a coordinator to prepare documents and letter of guarantee for tender as well as always monitoring the progress of the bidding through government notifications.

In case of making quotations for private customers, the engineering and medical support department will conduct a site survey and design projects according to customer requirements and related standards. This includes the cost estimates for each project and pricing. The sales and marketing department then prepares quotations to offer prices to private customers.


3) Signing contracts with customers

All contracts prior to signing are always reviewed by external legal counsel. In the event that the Group wins the E-bidding with the customers of government hospitals, the Group’s sales and marketing department prepares bank guarantees and coordinates contract signing with customers. In the event that the Group and private customers can negotiate prices and conditions, the sales and marketing department will coordinate the contract signing with the customer.


4) Implementation of service, project work, or production and delivery according to the operational plan

After signing the contract with the customer for project work, the relevant parties will provide services for the project according to the planned implementation plan. The Purchasing Department will purchase tools and equipment according to the operational plan. The goods are issued by the warehouse department. Then, the engineering department selects sub-contractor for construction. The operation will be supervised by a team of engineers of the Group with expertise. In addition, there will be an operation meeting on the progress of the project with the executives every month.


If there is a change in the scope of work or duration of work, the Company will coordinate with customers and related parties to be able to manage work time and manage costs efficiently.


For the production and distribution of hemodialysis concentrate, the Purchasing Department will purchase raw materials into the warehouse. After that, the hemodialysis concentrate department will reimburse raw materials for production and proceed to produce hemodialysis concentrate in the specified quantity.


In the procurement process, the Group has prepared the Approved Vendor List to compare prices, quality, delivery time, payment terms and product and service warranty to be reviewed annually in order for the Group to receive the best conditions and to enable the purchasing department to work more flexibly.


All procurement of medical devices and equipment is subject to procurement approval according to the Group’s approval authority table. The Group manages the procurement by estimating the purchase of goods to meet the demand and not to store more than necessary. This includes considering the suitability for the installation and maintenance service plans of the Group that have been planned in advance. Most of the purchases are made from domestic distributors appointed by the Company having direct manufacturer for convenience in contacting insurance claims and maintenance services. Only equipment for the Pneumatic Tube System is directly imported from abroad.


5) Quality inspection and delivery

The engineering department will inspect the quality and standards of the project work including the quality of pure water to meet the specified standards. In addition, the Hemodialysis Concentrate Department will inspect the quality of the produced hemodialysis concentrate to meet the specified standards before delivering work and products to customers.


6) After sales service and system maintenance

For the design and installation service of pure water production system for hemodialysis and system maintenance including design and installation service of equipment of Pneumatic Tube System, the engineering department will have a plan to take care of the system maintenance within the specified period. They will repair if there is a problem that needs to be fixed so that customers can use the service of pure water production systems and Pneumatic Tube System safely and efficiently.

Raw Material Acquisition (Overall)

The Company recognizes the importance of internal management and control in procurement. In the Company's business operations, executives, employees, and related persons are required to manage procurement. Therefore, the Company has formulated a policy on procurement for the procurement department to manage by planning procurement and determining procurement methods. Prepare budgets and monitor and control procurement regularly. Procurement of chemicals, medical supplies, medical equipment, or other goods that are legal and purchased directly from manufacturers or designated distributors. Require vendor or service provider evaluations After every delivery of goods or services, to be used as information for making the next procurement or procurement decision, as well as to obtain a good partner. Have good governance principles and be a good and reliable trade partner. Deliver quality products/services at reasonable prices and provide Maximum benefits for the company

Production Policy (Overall)

Policy on production process management and cost control

As a company that operates activities in the production of products for hemodialysis, we have set a policy on production management, which is an important step in producing products or services to meet customer needs, from production to product delivery on time. We have set production planning, production planning steps, production steps, standard yield (% Standard yield), monthly production summary reports and problems found in production, and reviewing the production process, including reviewing the policy on production process management and cost control at least once a year.

Number of Raw-Material Distributors (Overall)

14

Production Capacity (Overall)

ItemUnitUsedCapacity
Irving Corporation Co., Ltd.Liter1001,525,631

Domestic/Overseas Purchase Proportion (Overall)

Raw MaterialSource CountryValue
Gallons and Gallon CapsThailand37.99
chemicalsThailand28.75
Stickers and Sticker LabelsThailand0.99

Nature of Business — Overview

Introduction

KT Medical Service Public Company Limited ("KTMS") The Company operates hemodialysis services in both hemodialysis clinics and hemodialysis units in hospitals (outsourced units).


The Company has three subsidiaries, namely Irving Corporation Limited ("IRV"), Medical Vision Company Limited ("MV") and Nephro Vision Company Limited ("NEP"). as follows


1) Irving Corporation Limited ("IRV") operates 4 main businesses:

1.1) Engaged in the business of providing design services; Install a pure water production system.

1.2) Production and distribution of hemodialysis solutions,

1.3) Design and decoration of hemodialysis facilities,

1.4) Distribution of hemodialysis facilities. Design, assembly and distribution of medical devices for hemodialysis facilities.


2) Medical Vision Co., Ltd. ("MV") engages in the design and installation of air duct equipment, medical specimens, as well as system maintenance services.


3) Nephro Vision Company Limited ("NEP") operates hemodialysis services in both hemodialysis clinics and hemodialysis units in hospitals


The establishment of NEP will mainly be a collaboration with local nephrologists to make nephrologists feel a sense of co-ownership. NEP was also benefited from government SME support policies that can bid 10% higher than competitors in e-bidding. Subject to the government rule, more than 30% of the total employment must be employed with SME companies. This is an opportunity for SME entrepreneurs to bid for projects with the government sector.

Product Information — Overview

Introduction

The Group operates a complete business with international quality and standards for government hospital customers and private customers. The value chain of the Group’s business operations related to hemodialysis and integrated medical services can be detailed as follows:

Projects Under Construction

Has Projects Under Construction (Y/N)

Yes

Description

As of December 31, 2024, the Group had undelivered works totaling approximately 15.93 million baht. Currently, the Company has received orders for the installation of water systems from customers for 5 projects worth a total of 6.77 million baht and 2 projects for the renovation of hemodialysis units worth 2.16 million baht. The installation is expected to be completed in the first quarter of 2025 and 2) Medical Vision Co., Ltd. is currently receiving orders for the installation of air ducts. Medical specimens from customers have been completed in 3 projects with a total value of 7.00 million baht. The installation is currently in the process of being installed and is expected to be completed in the first quarter of 2025.

Total Projects

6

Total Project Value

5.03

Recognized Value

0.0

Remaining / Unrecognized Value

5.03

Projects

Project NameValueIncome %Est. YearsEst. MonthsEst. Completion
Installation of 1,200 liters of water system (1 job)1100032026-03-01
Installation of 1,500 liters of water system (1 job)1100032026-03-01
Wastewater treatment system installation (3 projects)0100032026-03-01
Installation of air ducts for transporting medical specimens at 8 stations (1 job)1100022026-02-01

Debentures & Bills of Exchange

Has Debentures (Y/N)

No

Convertible Securities

Has Convertible Securities (Y/N)

No

Contents